Clongen Laboratories Forms Separate Clinical Dx, Contract Research Branches | GenomeWeb

Clongen Laboratories, a Maryland-based CLIA-licensed testing facility, said this week that it has recently formed separate divisions for clinical diagnostics and contract research services.

Clongen's clinical diagnostics division specializes in screening a wide range of infectious diseases, primarily using real-time PCR. The Germantown-based company has historically focused on testing for tick-borne illnesses, but said that it also now offers more than 250 infectious disease assays, some of which are not offered anywhere else in the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.